Diabetes & Metabolism Journal

Scope & Guideline

Leading the way in diabetes and metabolic disorder advancements.

Introduction

Explore the comprehensive scope of Diabetes & Metabolism Journal through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Diabetes & Metabolism Journal in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2233-6079
PublisherKOREAN DIABETES ASSOC
Support Open AccessYes
CountrySouth Korea
TypeJournal
Convergefrom 2011 to 2024
AbbreviationDIABETES METAB J / Diabetes Metab. J.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address101-2104, LOTTE CASTLE PRES, 109 MAPO-DAERO, MAPO-GU, SEOUL 04146, SOUTH KOREA

Aims and Scopes

The Diabetes & Metabolism Journal focuses on a wide range of topics related to diabetes and metabolic disorders, emphasizing clinical research, novel therapeutic approaches, and the integration of technology in diabetes management.
  1. Clinical Management of Diabetes:
    The journal publishes studies on clinical guidelines, treatment efficacy, and safety profiles of various antidiabetic medications, including SGLT2 inhibitors, GLP-1 receptor agonists, and insulin therapies.
  2. Pathophysiology of Diabetes:
    Research articles delve into the underlying mechanisms of diabetes and its complications, exploring metabolic pathways, genetic factors, and the role of insulin resistance.
  3. Innovative Therapeutic Approaches:
    The journal highlights emerging therapeutic strategies, including pharmacological innovations, lifestyle interventions, and the use of digital health technologies in diabetes management.
  4. Epidemiological Studies:
    It presents findings from population-based studies that assess the prevalence, risk factors, and long-term outcomes of diabetes and related conditions, particularly within specific demographics.
  5. Comorbidities and Complications:
    The focus extends to the relationship between diabetes and other health issues, such as cardiovascular diseases, kidney diseases, and mental health conditions, emphasizing the need for comprehensive care.
The journal is witnessing a shift towards several emerging themes that reflect current trends and innovations in diabetes research and management.
  1. Digital Health and Technology Integration:
    There is a growing focus on the use of digital tools for diabetes management, including mobile applications and continuous glucose monitoring systems, highlighting the importance of technology in improving patient outcomes.
  2. Personalized Medicine and Genetic Insights:
    Research on personalized treatment strategies based on genetic and phenotypic profiles is on the rise, aiming to tailor diabetes management to individual patient needs.
  3. Microbiome and Gut Health:
    Emerging studies are investigating the role of the gut microbiome in metabolic health and diabetes, suggesting new avenues for therapeutic interventions.
  4. Impact of Lifestyle Factors:
    There is an increasing emphasis on the influence of lifestyle choices, such as diet, physical activity, and mental health, on diabetes management and prevention.
  5. Diabetes in Special Populations:
    Research focused on diabetes in specific populations, such as the elderly, pregnant women, and ethnic minorities, is expanding, addressing unique challenges and health disparities.

Declining or Waning

While the Diabetes & Metabolism Journal continues to evolve, certain themes have seen a decline in prominence over recent years, reflecting changes in research priorities and emerging challenges in the field.
  1. Traditional Dietary Interventions:
    Research focusing solely on conventional dietary approaches for diabetes management has decreased, as interest shifts toward more personalized nutrition and the impact of ultra-processed foods.
  2. Basic Science of Diabetes:
    There has been a noticeable decline in studies that focus exclusively on basic science aspects of diabetes without direct clinical implications, as the journal increasingly prioritizes translational research.
  3. Single-Agent Pharmacotherapy:
    The exploration of single-agent therapies is waning, as the trend moves towards combination therapies and multi-faceted approaches to diabetes treatment.
  4. Longitudinal Studies in Limited Cohorts:
    While longitudinal studies remain important, those focusing on narrow or less diverse populations are becoming less frequent, with a greater emphasis on larger, more representative cohorts.

Similar Journals

Diabetes Therapy

Transforming diabetes management with cutting-edge insights.
Publisher: SPRINGER HEIDELBERGISSN: 1869-6953Frequency: 6 issues/year

Diabetes Therapy is a prominent open access journal published by SPRINGER HEIDELBERG, dedicated to advancing our understanding of diabetes management and therapeutic strategies. Since its inception in 2010, the journal has provided a platform for high-quality research, showcasing innovative studies and clinical advances aimed at improving care for individuals with diabetes. With an established impact factor and categorized within the Q2 quartile in both Endocrinology, Diabetes and Metabolism and Internal Medicine in 2023, it ranks among the top journals in its field, reflecting its significant contribution to medical knowledge. Researchers, healthcare professionals, and students benefit from its comprehensive coverage of critical topics, ranging from pharmacological advancements to lifestyle interventions and cutting-edge technologies in diabetes management. With a Scopus rank placing it 35th in Internal Medicine, and 68th in Endocrinology, Diabetes, and Metabolism, Diabetes Therapy is recognized for its robust peer-reviewed content, making it an essential resource for anyone engaged in diabetes research and care.

DIABETES CARE

Leading the way in diabetes research excellence.
Publisher: AMER DIABETES ASSOCISSN: 0149-5992Frequency: 12 issues/year

DIABETES CARE, published by the American Diabetes Association, is a premier journal dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 1978, this journal has maintained a commitment to disseminating high-quality research, evidenced by its prestigious ranking in the Q1 category across multiple fields including Advanced and Specialized Nursing, Endocrinology, Diabetes and Metabolism, and Internal Medicine. With an impressive impact factor and distinguished Scopus rankings, DIABETES CARE serves as an essential resource for researchers, clinicians, and students alike, facilitating the exchange of knowledge and fostering innovation in diabetes care. Although not an open-access publication, the journal offers various ways to access groundbreaking studies and advancements in the field. This commitment to excellence reflects the journal's vital role in shaping diabetes research and clinical practices globally.

Current Diabetes Reports

Empowering clinicians with cutting-edge insights.
Publisher: CURRENT MEDICINE GROUPISSN: 1534-4827Frequency: 12 issues/year

Current Diabetes Reports is a leading academic journal published by CURRENT MEDICINE GROUP, dedicated to advancing research and clinical practices in the field of diabetes and endocrinology. With an impressive impact factor and ranked in the prestigious Q1 category for both Endocrinology, Diabetes and Metabolism and Internal Medicine, this journal serves as a vital resource for researchers, clinicians, and students alike. Established in 2001 and converging years up to 2024, Current Diabetes Reports aims to disseminate high-quality, peer-reviewed research articles, reviews, and clinical studies that address the multifaceted challenges of diabetes management and treatment. As it continues to thrive within a robust international community, the journal provides critical insights that are essential for improving patient outcomes and informing public health policies in the United States and beyond.

DIABETES-METABOLISM RESEARCH AND REVIEWS

Transforming Understanding through Cutting-edge Research
Publisher: WILEYISSN: 1520-7552Frequency: 8 issues/year

DIABETES-METABOLISM RESEARCH AND REVIEWS, published by WILEY, is an esteemed academic journal focusing on the forefront of research in the fields of endocrinology, diabetes, and metabolism. Since its inception in 1999, this journal has become a crucial resource for researchers, professionals, and students, boasting an impressive impact factor that reflects its high citation rates and contribution to the field. With a 2023 classification of Q1 in several categories including Endocrinology and Internal Medicine, it ranks among the top journals globally, demonstrating its significant influence and authority. The journal serves as a platform for the dissemination of innovative research, reviews, and methodologies that advance understanding and treatment of metabolic disorders. By offering valuable insights and fostering collaboration within the scientific community, DIABETES-METABOLISM RESEARCH AND REVIEWS is essential reading for anyone involved in diabetes research and clinical practice.

Metabolic Syndrome and Related Disorders

Fostering Dialogue on Metabolic Health Innovations
Publisher: MARY ANN LIEBERT, INCISSN: 1540-4196Frequency: 10 issues/year

Metabolic Syndrome and Related Disorders is an esteemed journal published by MARY ANN LIEBERT, INC, focusing on the multifaceted aspects of metabolic syndrome, including its interaction with chronic diseases such as diabetes, cardiovascular conditions, and obesity. Since its inception in 2003, this journal has established itself as a vital resource for researchers, healthcare professionals, and students dedicated to advancing knowledge in the fields of endocrinology, internal medicine, and metabolic disorders. With an impact factor reflective of its academic significance, Metabolic Syndrome and Related Disorders is recognized within the Q2 and Q3 quartiles in its respective categories, solidifying its reputation among scientific and clinical communities. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and reviews that foster innovative solutions and improve patient outcomes. The journal's gradual convergence towards 2024 presents an exciting opportunity for continued exploration and dialogue about metabolic-related health challenges.

Austrian Journal of Clinical Endocrinology and Metabolism

Fostering collaboration in endocrinology and metabolism.
Publisher: SPRINGER WIENISSN: 1998-7773Frequency: 4 issues/year

Austrian Journal of Clinical Endocrinology and Metabolism, published by SPRINGER WIEN, serves as a pivotal platform for the dissemination of research in the field of endocrinology, diabetes, and metabolism. With its ISSN 1998-7773 and E-ISSN 1998-7781, this journal has been contributing valuable insights to the field since its inception in 2010. Although it currently holds a Q4 ranking in the category of Endocrinology, Diabetes and Metabolism, it is committed to improving its impact factor by showcasing high-quality, peer-reviewed articles that reflect contemporary challenges and innovations in clinical endocrinology. Located in Vienna, Austria, the journal aims to provide researchers, healthcare professionals, and students with access to the latest findings and clinical practices that advance understanding and treatment of endocrine disorders. Researchers interested in submitting their work will find a supportive environment that embraces both experimental and clinical approaches. The Austrian Journal of Clinical Endocrinology and Metabolism is poised to become a valuable resource for those dedicated to improving health outcomes in metabolic disorders.

DIABETIC MEDICINE

Shaping the future of endocrinology through innovative research.
Publisher: WILEYISSN: 0742-3071Frequency: 12 issues/year

DIABETIC MEDICINE is a leading peer-reviewed journal published by Wiley, dedicated to advancing the field of endocrinology, specifically focusing on the pathophysiology, management, and prevention of diabetes mellitus and its complications. With an impressive impact factor reflecting its significant role in shaping clinical practice and research, DIABETIC MEDICINE holds a prominent position among its peers, categorized in the Q1 quartiles for Endocrinology, Diabetes and Metabolism, and Internal Medicine. Since its inception in 1984, the journal has provided a platform for rigorous and innovative research, fostering collaborative efforts among researchers, clinicians, and students to enhance diabetes care. The journal is esteemed for its high-ranking performance in Scopus, highlighted by its ranking of #33 in Internal Medicine and #64 in Endocrinology, Diabetes, and Metabolism. By offering insightful access to groundbreaking studies and reviews, DIABETIC MEDICINE plays a crucial role in informing policy and improving medical outcomes for individuals with diabetes, making it an essential resource for those in medical and clinical research fields.

Clinical Obesity

Empowering Change Through Evidence-Based Insights
Publisher: WILEYISSN: 1758-8103Frequency: 6 issues/year

Clinical Obesity, published by WILEY, is a leading journal in the field of Endocrinology, Diabetes, and Metabolism that strives to advance the understanding of obesity-related health issues. With an ISSN of 1758-8103 and an E-ISSN of 1758-8111, this journal provides a platform for cutting-edge research and findings pertaining to the epidemiology, pathophysiology, prevention, and treatment of obesity. Recognized with a Q2 ranking in both Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous) categories, and boasting a Scopus rank of #90 out of 244, Clinical Obesity encompasses innovative studies that influence clinical practice and public health policies. While this journal operates under a subscription model, its discipline-specific contributions are invaluable for researchers, healthcare professionals, and students keen on addressing the complexities of obesity in a comprehensive manner.

Journal of Diabetes Investigation

Pioneering insights for improved diabetes care.
Publisher: WILEYISSN: 2040-1116Frequency: 6 issues/year

Journal of Diabetes Investigation is a prestigious open-access journal published by WILEY, dedicated to advancing knowledge in the fields of Endocrinology, Diabetes, and Metabolism. With its ISSN 2040-1116 and E-ISSN 2040-1124, the journal provides a vital platform for researchers, healthcare professionals, and students to disseminate high-quality research, foster innovative ideas, and engage with cutting-edge developments in diabetes investigation. Since its inception in 2010, the journal has established a solid reputation, ranking in Q2 for Endocrinology and Diabetes and Metabolism, and Q1 for both Internal Medicine and Miscellaneous Medicine categories in 2023. Its Scopus rankings further underscore its impact, notably at the 76th percentile in Internal Medicine. The open access model, adopted in 2014, ensures that vital information is freely available, promoting global collaboration and knowledge sharing. The journal is not only a reflection of Australia's commitment to medical research but also a beacon for advancements that can ultimately enhance patient outcomes in diabetes care.

Journal of Diabetology

Driving progress in diabetes research and treatment.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2543-3288Frequency: 3 issues/year

The Journal of Diabetology, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 2010, this Open Access journal has provided researchers and healthcare professionals with a wealth of knowledge through rigorous peer-reviewed articles that cover clinical research, epidemiology, and innovative treatment strategies. With an E-ISSN of 2078-7685 and a commitment to disseminating high-quality scientific work, the journal plays a pivotal role in contributing to the global discourse on diabetes care and prevention. Its dedication to accessibility enhances its impact on both established scholars and emerging researchers seeking to make meaningful contributions in the field. By fostering a collaborative environment, the Journal of Diabetology aims to bridge the gap between research and practical implementation, ultimately improving outcomes for individuals affected by diabetes.